In large-scale multi-site clinical studies from the US, [ 8 ] highly significant MMN (Cohen’s d, d=0.96) amplitude reductions were observed in SZ patients, it is so far probably the most promising neurophysiological biomarkers to be used to guide assignment of patients to clinical interventions.
← all excerpts
Mismatch Negativity in Han Chinese Patients with Schizophrenia: A Meta-Analysis.
1
—
—